KAPA
Kairos Pharma, Ltd.
NYSE MKT: KAPA · HEALTHCARE · BIOTECHNOLOGY
$0.55
-6.44% today
Updated 2026-04-29
Market cap
$12.83M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.30
Dividend yield
—
52W range
$0 – $2
Volume
0.6M
Kairos Pharma, Ltd. (KAPA) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | $14308.00 | $775000.00 | $1.04M | $965000.00 | $6.22M |
| Cash & equivalents | $14308.00 | $73000.00 | $437000.00 | $93000.00 | $1.27M |
| Current assets | $14308.00 | $73000.00 | $437000.00 | $101000.00 | $4.17M |
| Total liabilities | $357146.00 | $1.94M | $2.21M | $3.04M | $1.44M |
| Current liabilities | $357146.00 | $1.94M | $1.63M | $2.40M | $992000.00 |
| Long-term debt | — | — | $582000.00 | $638000.00 | — |
| Shareholder equity | $-342838.00 | $-1.17M | $-1.18M | $-2.08M | $4.78M |
| Retained earnings | $-1.20M | $-3.35M | $-4.40M | $-6.21M | $-8.81M |
| Accounts receivable | — | — | — | — | — |
| Inventory | — | — | — | — | — |
| Goodwill | — | — | — | — | — |